The 4 Corners of Cardiology Meeting Organising Committee are pleased to announce the following invited speakers:
Dr Sonya Burgess
Dr Sonya Burgess ( MBChB, BSc, FRACP, FCSANZ, SCAI-ELM ) is an Interventional Cardiologist working in Sydney, at Nepean Public hospital, South West Cardiology, and Sydney South West Hospital, and is an HMO at Liverpool hospital where she is completing her PhD with the University of New South Wales. Dr Burgess is a 2019-2021 SCAI Emerging Leader Fellowship Program member and is 1 of only 19 female interventional cardiologists in Australia and New Zealand. She is a co-founder of the Women in Interventional Cardiology of Australia and New Zealand (WiiCAN) and Women in Cardiology (WIC) groups. Dr Burgess has a particular interest in STEMI, incomplete revascularization, multi vessel disease, and the residual SYNTAX score, the topic of her PhD, she has presented her research at EuroPCR, ESC and at TCT, where she is also 2019 invited faculty. She has, in the last year, had first author papers published in JACC, JAMA Cardiology, Circulation, IMJ and the AHJ.
Prof Derek Chew
Prof Derek Chew, Lifelong Health Theme Leader, South Australian Health and Medical Research Institute (SAHMRI)
Professor of Cardiology, Flinders University, South Australia
Network Director of Cardiology, Southern Adelaide Health Local Health Network, South Australia.
Derek Chew is a clinical and interventional cardiologist as well as a clinical trialist and outcomes researcher in cardiovascular medicine. He has completed a Masters of Public Health at the Harvard School of Public Health, with formal training in epidemiology, trial design, biostatistics, clinical trials and cost-effectiveness analysis. His PhD thesis explored the factors for improving heart attack care in Australia. His current appointment is Professor of Cardiology Flinders University and is the Network Director of Cardiology for the Southern Adelaide Health Local Health Network. He leads the Heart and Vascular program of the SAHMRI and co-leads the Lifelong Health Theme. He has national and international roles in chest pain/ACS evidence generation, assimilation and translation. In clinical guideline development he has led the Heart Foundation/CSANZ ACS Guidelines writing group 2016and served on the European Society of Cardiology Guidelines for the management of ACS Writing committee2015. In addition, he chairs the Cardiovascular Disease Expert Advisory Group, the primary CV disease monitoring body of the AIHW; while providing expert advice to the Australian Commission for Quality and Safety in Health care). He also Chairs the Quality Standards Committee of the Cardiac Society of Australia and New Zealand, and the Clinical Committee of the Heart Foundation. He has authored over 280 manuscripts and book chapters.
Prof Andrew Coats AO
Professor Henry Krum Memorial Lecture
Prof Andrew Coats AO
Andrew, DM (Oxon), DSc. (Imperial), MBA, born in Australia and a graduate of Oxford and Cambridge, was Viscount Royston Professor at Imperial College, Director of Cardiology at Royal Brompton Hospital, Dean of Medicine and DVC at Sydney and CEO of the Norwich Research Park. He was also director of the Monash Warwick Alliance. Andrew has 87,000 citations (H-index 127) in the filed of heart failure research and has led many major clinical trials. Andrew received the Linacre Medal (Royal College of Physicians) and Michael L Pollock award (American Heart Association). Andrew co-founded PsiOxus therapeutics and served as editor-in-Chief of the International Journal of Cardiology 1999-2016.
Prof Stephen Duffy
Prof Stephen Duffy is a practicing interventional and general cardiologist at The Alfred Hospital, Melbourne, Australia, where he was Head of Cardiology General Services from 2005 to 2018. He is currently an Adjunct Professor, Department of Epidemiology and Preventative Medicine, Monash University. His clinical and research interests include interventional cardiology, management of acute coronary syndromes and structural heart disease. Together with Associate Professor Tony Walton, he established the first transcatheter aortic valve implantation (TAVI) program in the state of Victoria in 2008 and has been treating patients with this technology for nearly eleven years. He has published over 150 manuscripts, and is a Chief Investigator on a NHRMC Centre of Research Excellence Grant. Presently he serves as the elected representative from Victoria on the Cardiac Society of Australia and New Zealand (CSANZ) Board and was Convenor of the CSANZ Annual Scientific Meeting in 2019. He is also on the Steering Committee of the Victorian Cardiac Outcomes Registry and the Melbourne Interventional Group registry.
Prof Murray Esler
Professor Murray Esler is a cardiologist and medical scientist, based in Melbourne. He is a Senior Director of the Baker Heart and Diabetes Institute, Melbourne, an Adjunct Professor of Medicine of Monash University, and a Fellow of the Australian Academy of Science. His research field is cardiovascular neuroscience, within which his research interests are stress and its effects on the heart and blood pressure, the causes and treatment of high blood pressure and heart failure, and the neurotransmitters of the human brain. Prof. Esler’s principal research contribution has been the development of isotope dilution methodology to study the human sympathetic nervous system, and the application of this tool in the investigation of the sympathetic neural physiology of circulatory control, aging, exercise and mental stress responses, and the neural pathophysiology of cardiac failure and essential hypertension. His demonstration of a high level of chronic activation of the cardiac sympathetic outflow in patients with heart failure provided the theoretical basis for the evaluation of beta-adrenergic blockers in this condition. More recently, his demonstration of activation of the renal sympathetic outflow in essential hypertension was a stimulus for the development of radio-frequency ablation of the renal sympathetic nerves for resistant hypertension.
Prof John French
Prof John French major clinical research focus has been in the acute coronary syndromes, particularly on the assessment of myocardial reperfusion assessed by infarct-related artery blood flow, ST recovery, left ventricular function, and late clinical outcomes in patients with ST elevation myocardial infarction. He has been an active researcher having been an investigator and co-investigator in numerous randomised controlled trials and clinical trials and was on the writing committee of the HERO-2 trial. John was on the steering committee for the SHOCK, OAT and HERO-2 trials and he was the chair of the myocardial infarction adjudication committee and ECG sub-study for HERO-2. As part of a continuing interest in molecular medicine John has established the cardiac genetics clinics with the genetics department, and is a member of TRAGADY. John has co-authored >120 peer-reviewed publications and six book chapters. He has supervised a number of MD and MHSc postgraduate students and has been invited speaker at recent American College and American Heart Association meetings.
Dr Belinda Gray
Dr Belinda Gray ( BSc(Med) MBBS PhD FRACP) is an Academic Cardiologist and NHMRC Early Career Fellow. Dr Gray graduated in medicine from the University of NSW in 2006 and completed her cardiology training at Royal Prince Alfred Hospital in 2013. She completed her PhD at the University of Sydney in 2016 in Genetic Heart Disease and Sudden Cardiac Death with the support of a Heart Foundation PhD Scholarship. She then undertook a 2 year postdoctoral fellowship in Sports Cardiology and Inherited Cardiac Conditions at St George’s, University of London, UK. Dr Gray’s research focuses on risk stratification, genetics and prevention of sudden cardiac death in the young, including young athletes. Dr Gray is a module lead and lecturer in the Masters of Sports Cardiology (MSc) at St George’s, University of London.
Prof Christoper Hayward
Prof Hayward is a senior staff Cardiologist with the Heart and Lung Transplant Unit at St Vincent’s Hospital, Sydney, and on Faculty at the Victor Chang Cardiac Research Institute. He has academic appointments at the University of New South Wales, Sydney and the University of Technology, Sydney and is a Life Member of the National Heart Foundation of Australia. He is internationally recognised in management of patients with mechanical circulatory devices – ‘artificial hearts’ with other areas of interest including the management of patients with severe advanced heart failure. He has served as Vice President for the National Heart Foundation (NSW Division) Board, and on the Human Research and Ethics Committee for the St Vincent’s and Mater Health Service.
Dr Jeroen Hendricks
Dr Jeroen Hendriks is an Academic Nurse and Health Scientist who received his PhD in 2013 at Maastricht University Medical Centre, Maastricht, the Netherlands. His doctoral studies focused on developing Integrated Care in terms of specialised Arial Fibrillation clinics and proving the role of specialised nurses to manage these clinics. He is a Senior Lecturer at the Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital. His program of research focuses on integrated care management in atrial fibrillation and related cardiovascular conditions, as well as preparing and redesigning practices for implementation of such approach.
Dr Hendriks holds a Future Leader Fellowship from the Australian Heart Foundation. Dr Hendriks is the President of the Australian Health and Cardiovascular Rehabilitation Association (ACRA) SA/NT. He is Deputy Chair of the Science Committee – European Society of Cardiology’s Association on Cardiovascular Nursing and Allied Professions, and is member of the Scientific Sessions Program Committee – Heart Rhythm Society. He served on the Task Force Writing Committee to develop the 2016 European Society of Cardiology Guidelines for the management of Atrial Fibrillation, and on the Writing Committee to develop the 2018 Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation. He is Editorial Board member of the European Journal of Cardiovascular Nursing, The International Journal of Care Coordination, and ICT & Health International.
Prof John McNeil
Prof John McNeil originally graduated in Medicine from the University of Adelaide in and after specialist training he completed a PhD in Cardiovascular Pharmacology at Melbourne University. In 1979 he was awarded a National Heart Foundation overseas postgraduate research scholarship to study epidemiology at the London School of Hygiene & Tropical Medicine. He was head of Monash University’s Department of Epidemiology and Preventive Medicine (DEPM) 1986 to January 2019. The department has been based around core of methodological skills in epidemiology, clinical medicine, biostatistics & data-management. Much of the work of the department now centres on large scale clinical trials, clinical registries and major occupational cohorts.
John McNeil is the co-principal investigator of the joint US-Australia NIH-funded ASPREE trial of low-dose aspirin in the elderly. Various sub-studies will ensure that ASPREE will become a major international resource for study of the elderly. His other major interest in in clinical registry science.
Dr Chrishan Nalliah
Dr Nalliah is an academic cardiac electrophysiologist who completed cardiology training and obtained qualification as a Fellow of the Royal Australasian College of Physicians from Westmead Hospital. He subsequently undertook a fellowship in cardiac electrophysiology at the Royal Melbourne Hospital and completed a PhD exploring novel mechanisms of atrial fibrillation at the University of Melbourne. His thesis focused on the role of sleep apnoea, obesity and epicardial adiposity on the mechanism of AF. He is presently completing a post-doctoral fellowship at Westmead Hospital exploring mechanisms of ventricular tachycardia. His interest lays in understanding arrhythmia mechanisms and strategies for optimising management.
Dr Shane Nanayakkara
Dr Shane Nanayakkara is a cardiology fellow at the Alfred Hospital, with interests spanning across heart failure as well as coronary and structural intervention. Shane has recently completed a PhD in heart failure with preserved ejection fraction, with studies extending from animal and human studies over to artificial intelligence. Shane is interested in the intersection between heart failure and intervention, as well as the role of artificial intelligence and machine learning and their application within cardiology.
Prof Mark Nelson
Prof Mark Nelson is Professor and Chair, Discipline of General Practice, School of Medicine and Senior Member Menzies Institute for Medical Research where he is also medical director of the Blood Pressure Clinic, both at the University of Tasmania, Hobart Australia. He is also an Adjunct Professor, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne Australia. His research interests are around large-scale clinical trials in in primary care. He has 265 peer reviewed scientific publications, has been awarded more than AU$80 million in competitive grants and is a principal investigator on the NIH sponsored ASPREE / ASPREE-XT study (N = 19,000) investigating if aspirin extends healthy active life, and the NHMRC sponsored STAREE (recruitment to date >5500) similarly investigating if statins extend healthy active life. He also has been an author on multiple guidelines for cardiovascular disease prevention and treatment and remains in clinical general practice in Hobart Australia.
A/Prof Rajeev Pathak
A/Professor Rajeev K. Pathak, MBBS, PhD, FRACP, FHRS, FACC is an Cardiac Electrophysiologist, Clinical Director of Cardiac Electrophysiology & Pacing at the Canberra Hospital and Australian National University, Australia. He completed his residency and advanced training in Cardiology at The Canberra Hospital, before pursuing sub-specialisation in Cardiac Electrophysiology at the Royal Adelaide Hospital. He did his post-doctoral advanced cardiac electrophysiology fellowship at University of Pennsylvania, USA. Dr Pathak has received multiple national and international academic honours and has published widely in the field of cardiac electrophysiology.
Prof Hari Raju
Prof Hari Raju is a Cardiologist and Electrophysiologist at Macquarie University and Concord Hospitals in Sydney. His research and clinical expertise in unexplained sudden death and genetic heart disease was developed during his PhD study at St George’s in London. His research in this area has been recognised by the international community and published in high-profile journals. Moreover, he won the Young Investigator Award at Heart Rhythm Congress in 2013 for his research focusing on genetics of sudden death. He was fortunate to be trained by Profs Elijah Behr and Jitendra Vohra, who were the UK and Australian representatives on the 2013 international expert consensus statement on inherited primary arrhythmia syndromes.
Prof Carl Schultz
Professor Carl Schultz is the Chair in Cardiology and Interventional Cardiologist at the Royal Perth Hospital Campus of the University of Western Australia where he is pursuing research interests in risk stratification of and novel therapies for prevention of cardiovascular heart disease since 2013. He is the Director of Clinical Trials in the Department of Cardiology and Chair of the research committee with the School of Medicine, University of Western Australia. He trained in clinical medicine in South Africa before obtaining a PhD in clinical epidemiology at the University of Oxford. He trained in Cardiology in Cambridge, Manchester and London before taking up a fellowship in interventional cardiology under Professor Patrick Serruys and cardiac CT-angiography under Professor Pim de Feyter at the Thoraxcentre in Rotteram, the Netherlands where he then stayed on as staff member and University Medical Specialist for several years. He has over 130 publications in peer reviewed journals, several text book chapters and speaking invitations to national and international conferences. As a busy clinician he treats patients with cardiovascular disease on a daily basis. His research interests are on primary and secondary prevention and include risk stratification.
Prof Andrew Sindone
Prof Andrew Sindone B. Med (Hons), MD, FRACP, FCSANZ is Director of the Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital and Cardiologist, Ryde Hospital with private practice in Eastwood and Westmead.
Professor Sindone studied Medicine at the University of Newcastle and graduated with First Class Honours and the University Medal in 1987. He completed his Residency at Royal North Shore Hospital, Physicians’ Training at Concord Hospital, Cardiology Advanced Training at St. Vincent’s Hospital and Doctorate through University of NSW.
He has been involved in research, teaching and improving the lives of those with cardiovascular disease for over twenty-seven years. He established the Heart Failure Unit at Concord Hospital with its Clinic, research, rehabilitation and outreach programs. He teaches medical students, junior doctors, General Practitioners and cardiologists.
Professor Sindone has received multiple awards, Grants, has been Principal Investigator in over 35 international multicentre clinical trials, has presented over 85 research papers and continues to publish in cardiology. He is Co-Chair of the NSW Cardiovascular Expert Reference Group, was on the Scientific Committee for the World Congress of Cardiology, is co-author of the Australian Heart Failure Guidelines and is on over 35 pharmaceutical advisory boards. He is patron of multiple charities and supports the Italian Community with heart disease.
A/Prof Gopal Sivagangabalan
A/Prof Gopal Sivagangabalan completed his Cardiology and interventional training at Westmead Hospital. Following completion of a PhD through the University of Sydney he undertook a combined research/clinical fellowship in Electrophysiology and Pacing at the Toronto General Hospital. In addition to his appointment as the Head of Cardiology Department at Auburn hospital and the Clinical lead for Cardiac Pacing and Defibrillation at Westmead hospital, Gopal’s extensive clinical career has focused on all aspects of procedural cardiology from electrophysiology and ablation, to complex device implantation, to coronary intervention. He also has extensive experience with reporting cardiac CT. Gopal’s passion for education is clear, running several successful device implant courses to train and upskill both Australian and international colleagues, particularly in CRT.
A/Prof Dion Stub
A/Prof Dion Stub is an Interventional Cardiologist and clinician scientist specializing in coronary and structural heart intervention. He has published over 90 peer reviewed manuscripts and delivered multiple presentations in both cardiac emergencies and structural heart intervention, and has been internationally recognized for his research.
He currently holds the National Heart Foundation Future Leader Fellowship to support his clinical research. Dion spent 2 years overseas in USA and Canada, as a post doctorate fellow, with the support of a Victoria Fellowship, Royal College of Physicians and Australian Cardiac Society awards.
He is a staff specialist at The Alfred and Western Health. He is senior research fellow with Monash University and Baker IDI Heart and Diabetes institute, medical adviser to Ambulance Victoria and Australian and New Zealand Cardiac society representative on Australia Resuscitation Council.
Prof Andrew Taylor
Prof Taylor works in the Heart Failure and Heart Transplant service, where he is Director of Cardiac Magnetic Resonance (CMR) Imaging and Head of Cardiac CT. He is also an Honorary Scientist at the Baker Heart and Diabetes Institute, and a Director of the National Heart Foundation (Victorian Branch). He completed his PhD in the microvascular effects of atherosclerotic plaque rupture, with work from his thesis selected as a finalist in the CSANZ Ralph Reader Basic Science Prize and winning the Young Investigator Award of the European Society of Cardiology in 2001. After completing a fellowship in CMR in Berlin in 2002, he has developed novel CMR applications for the characterisation of cardiac fibrosis, and evaluated the relationship between cardiac fibrosis and cardiovascular disease. Through CMR T1 mapping techniques, his group was the first in the world to non-invasively assess diffuse myocardial fibrosis with CMR imaging, with subsequent work as senior supervisor being awarded the CSANZ Ralph Reader Clinical Science Prize in 2011. His group have also applied conventional CMR techniques that identify regional myocardial fibrosis to identify patients with heart failure who are at high risk of future life threatening cardiac arrhythmia. Since 2005, he has generated over $4,000,000 of clinical and research funding and he has published over 110 peer reviewed articles, mostly as first or senior author. He has supervised 11 phd students (5 completed to date) as well as numerous imaging fellows, and he is a regular invited speaker at most local and international cardiology conferences. He has written editorials in the European Heart Journal, JACC and JACC Cardiovascular Imaging and serves as a reviewer for more than a dozen international journals, including Circulation and JACC.
Dr Gautam Vaddadi
Dr Gautam Vaddadi, Director of Cardiac Services at Cabrini Health, is a general adult cardiologist with expertise in a broad range of non-invasive cardiology. Dr Vaddadi’s interests include general cardiology, heart failure, syncope, postural hypotension, echocardiography and stress echocardiography. He graduated in medicine from the University of Melbourne in 1999 and was awarded a Bachelor of Medical Science for research at the Baker Heart Research Institute. He completed basic physician training at Austin Health in 2003 and undertook advanced training in Cardiology, Heart failure and Transplantation at The Alfred Hospital, Melbourne from 2004 to 2006. He progressed his post graduate studies investigating the mechanisms of syncope (low blood pressure and fainting) from 2006 to 2009. This work resulted in several high profile peer reviewed research publications in leading cardiovascular journals. Dr Vaddadi was awarded the Ralph Reader Prize by the Cardiac Society of Australia and New Zealand in 2008 for his research investigating syncope. His Public Hospital appointments include The Alfred Hospital and Northern Hospital. He is Head of Heart Failure Services at Northern Health, where he has been instrumental in building heart failure services in the Northern region of Melbourne, and actively engaged in a project, funded by the Department of Health, to investigate Heart failure services in primary care.
Prof Gerald F Watts
Prof Gerald F Watts, DSc MD PhD FRCP FRACP is a senior consultant physician, full professor and chair of The Familial Hypercholesterolaemia-Australasia Network. He trained at Imperial and King’s Colleges in the University of London before moving to Australia. He is currently lead of the Cardiometabolic Service (Departments of Cardiology and Internal Medicine) and Professor of Cardiometabolic Medicine at the Royal Perth Hospital and the University of Western Australia. Research interests include lipid disorders, obesity and cardiovascular prevention, and clinical interest focuses on delivering improved health care for FH and related conditions. Professor Watts is actively involved in teaching and supervisors several MD and PhD students and post-doctoral fellows. He has authored over 650 published works and is on the editorial board of Atherosclerosis, Clinical Science, Metabolism, Journal of Clinical Lipidology, and Current Opinion in Lipidology.
A/Prof Dominica Zentner
A/Prof Dominica Zentner trained in cardiology at the Royal Melbourne Hospital. She subsequently completed a PhD at the University of Melbourne, titled Cardiac Structure and Function during Human Pregnancy. She is on staff at the Royal Melbourne Hospital, participating both in the general cardiology and echocardiography services. Dominica has several cardiology sub-speciality interests. She consults at both the Adult Congenital Heart Disease service and the Cardiac Genetic Clinic at the Royal Melbourne Hospital, and was one of the founders of the Cardiac Pregnancy Clinic, a joint service run between the Royal Melbourne and Royal Women’s Hospitals. Dominica has an appointment with the Therapeutic Goods Association as a member of the Advisory Committee on Medicines. She is a member of the Quality Standards subcommittee of the Cardiac Society of Australia and New Zealand and is the Chair of the Victorian Division of CSANZ. She is also involved in ongoing clinical research projects and is involved in with national and international research collaborations.
Dr Ella Zomer
Dr Ella Zomer is a leading Australian, early career, epidemiological modeller in the School of Public Health and Preventive Medicine, Monash University. She has expertise in translating study findings through epidemiological and economic modelling, particularly for chronic disease. Following an undergraduate in Biomedical Science and doctorate in epidemiological modelling at Monash University, Ella gained international research experience at University College of London, where she was involved in health technology assessments, economic evaluations alongside clinical trials, and other health economic projects across the UK. Since returning to Monash, she has led numerous studies investigating the effectiveness and cost-effectiveness of cardiovascular prevention/treatment strategies.
Prof Sophia Zoungas
Sophia Zoungas is Professional Research Fellow at The George Institute and Head of Clinical Research and Diabetes Research Program within the School of Public Health, Monash University. She holds an National Heart Foundation CDA Fellowship and is a practising endocrinologist with clinical appointments at the RPAH Medical Centre, NSW and the Southern Health Care Network, Victoria. Sophia’s research focuses on the management of Type 2 diabetes and its complications. Sophia is the international coordinator of the ADVANCE-ON study, a global long-term post-trial follow up study of the ADVANCE cohort that seeks to examine the legacy effects of intensive glucose control and routine blood pressure lowering in people with type 2 diabetes.